Tempus ECG-Low EF vs EchoGo Pro
AI Verdict
Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if your primary goal is to efficiently screen patients aged 40 or older for potential low left ventricular ejection fraction (LVEF) using standard 12-lead ECGs. This tool is best suited for identifying patients at risk of heart failure early in the diagnostic pathway, enabling timely further evaluation.
View Tempus ECG-Low EF →Choose EchoGo Pro if…
Choose EchoGo Pro if you need to automate and enhance the analysis of stress echocardiograms for the accurate diagnosis of coronary artery disease (CAD). This cloud-based solution is ideal for cardiology departments seeking near-instant, comprehensive reports to improve diagnostic workflow and precision in specialized cardiac imaging.
View EchoGo Pro →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-Low EF | EchoGo Pro |
|---|---|---|
| Pricing | Unknown | Contact vendor for pricing |
| Deployment | Integrates with current ECG platforms and electronic health records (EHRs). | Cloud-based |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
EchoGo ProEchoGo Pro (Tool B) offers a cloud-based SaaS model that requires no software installation or extensive training, integrating seamlessly with existing PACS and clinical workflows (DICOM, HL7). In contrast, Tempus ECG-Low EF (Tool A) operates as software integrated into healthcare facility workflows without a dedicated user interface, relying on file exchange with other medical systems.
Clinical Value
TieBoth tools are FDA-cleared and provide significant clinical value by addressing critical cardiac conditions. Tempus ECG-Low EF (Tool A) offers early detection of low LVEF from standard ECGs, validated with high sensitivity and specificity. EchoGo Pro (Tool B) automates and improves the accuracy of stress echocardiography for CAD diagnosis, demonstrating over 90% AUROC and reducing misdiagnosis.
Pricing & Value
EchoGo ProEchoGo Pro (Tool B) provides more transparency regarding its pricing model, offering pay-per-use or subscription options, and explicitly mentions established reimbursement pathways for related products, including specific CPT codes and Medicare reimbursement details. While Tempus ECG-Low EF (Tool A) also has CPT codes for algorithmic ECG assessments, the detailed information on reimbursement and flexible models for Tool B offers a clearer financial value proposition for providers.
Enterprise Readiness
EchoGo ProEchoGo Pro (Tool B) demonstrates stronger enterprise readiness with its cloud-based SaaS deployment, vendor-neutrality, and seamless integration with standard clinical workflows (DICOM, HL7, PACS). This approach typically offers greater scalability and easier deployment compared to Tempus ECG-Low EF (Tool A), which is described as software integrated into facility workflows via standard communication protocols but without the same explicit emphasis on vendor-neutrality or cloud benefits.
Innovation
Tempus ECG-Low EFBoth tools represent innovative applications of AI in cardiology. However, Tempus ECG-Low EF (Tool A) is slightly more innovative by leveraging a widely available and inexpensive 12-lead ECG to detect signs of low LVEF, a critical indicator of heart failure risk, potentially enabling widespread early screening. This broadens the reach of advanced diagnostics to a larger patient population earlier in their care journey.
Support & Docs
Tempus ECG-Low EFTempus (Tool A) provides clear customer support channels via email and phone, and explicitly features a 'Document Library' with various forms, guidelines, and sample reports. While Ultromics (Tool B) also offers customer support and resources like a user manual and clinical dossiers, Tempus's detailed description of its document library and customer service roles suggests a more comprehensive and transparent approach to support and documentation in the available information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-Low EF | EchoGo Pro |
|---|---|---|
| Tool Name | Tempus ECG-Low EF | EchoGo Pro |
| Company | Tempus AI | Ultromics |
| Description | Tempus ECG-Low EF is an FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation. | EchoGo Pro is an FDA-cleared, AI-powered cloud solution by Ultromics that automates stress echocardiography analysis to improve the diagnosis of coronary artery disease, providing near-instant, accurate reports. |
| Primary Diagnostic Focus | Low Left Ventricular Ejection Fraction (LVEF u226440%) and heart failure risk | Coronary Artery Disease (CAD) |
| Input Data Type | 12-lead ECG recordings | Stress echocardiography |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and EchoGo Pro.
Frequently Asked Questions
More Comparisons
More matchups featuring Tempus ECG-Low EF or EchoGo Pro
Backers
Who funded each tool's parent company.